Table 3.
| Patient # | MRI tumor size (post-biopsy) | Pathology tumor size (post-RFA) |
|---|---|---|
| 01 | 1.5 cm | No Residual |
| 02 | 2.4 cm Enhancement | 1.3 cm but non-viable |
| 03 | 0.9 cm | 0.9 cm (IDC)/1 cm DCIS but non-viable |
| 04 | - | No Residual |
| 05 | - | No Residual - atypia |
| 06 | 1.2 cm | 2.5 cm — Non-Viable |
| 07 | Possible Minimal Residual | No Residual |
| 08 | 1 cm | < 1 cm — Non-Viable |
| 09 | 0.66 cm | No residual |
| 10 | 1cm | 0.8 cm — Non-Viable |
| 11 | 1 cm | 0.5 cm — Non-Viable |
| 12 | Minimal Residual Enhancement Seen | No Residual |
| 13 | 2 cm Enhancement | Residual Focus — Non-Viable |
| 14 | Mild Enhancement Seen | 0.2 cm — Non-Viable |
| 15 | Thin Rim of Enhancement | No Residual |